White & Case Advises Nordic Capital on Acquisition of Ober Scharrer Group
1 min read
Global law firm White & Case LLP has advised Nordic Capital Fund IX (Nordic Capital) on the acquisition of Ober Scharrer Gruppe GmbH (OSG), one of Germany's leading providers of ophthalmology products.
The seller is Palamon Capital Partners, a London-based private equity firm. The parties have agreed not to disclose financial details. The transaction is subject to approval by the relevant authorities.
Nordic Capital is a leading healthcare investor. With the acquisition of OSG, it is further expanding its portfolio in the healthcare sector in German-speaking countries. Since inception, Nordic Capital Funds has invested in more than 20 healthcare platforms in Europe and the USA.
OSG was established in Fuerth in 1982 and is Germany's largest provider of treatments for major causes of blindness and visual impairment, as well as non-invasive treatments and diagnosis of eye disorders. The group currently employs 900 people in around 80 clinics in Germany.
The White & Case team which advised on the transaction was led by partner Stefan Koch (Frankfurt) and included partner Hendrik Roehricht (Frankfurt) and associates Tomislav Vrabec, Hugo Schwarz Leite, Sebastian Brenner (all Frankfurt), as well as partners Axel Schulz (Brüssels), Tim Arndt (Frankfurt) and Matthias Kiesewetter (Hamburg), local partner Matthias Bochum (Hamburg), counsel Katrin Ruebsamen (Berlin) and associates Paul Kohlhaas, Anne-Sophie von Koester, Sandra D'Ascenzo (all Frankfurt), Sebastian Stuetze, Reinhard Sucker and Julia Cornelius (all Hamburg).
For more information, please speak to your local media contact.